21 May 2013
Keywords: Benitec Biopharma, Tacere Theapeutics, RNAi, Hepatitis C, M&A
Article | 15 October 2012
Australia-based Benitec Biopharma (ASX: BLT) said last Friday that it has executed an agreement to acquire the privately-held US RNA ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 October 2012
16 October 2012
© 2013 thepharmaletter.com